The idea that PMF may be diagnosed even in the presence of a non-fibrotic BM and differentiated from ET and PV, first came in the late twentieth century [18]. The concept of a pre-fibrotic PMF was ...

The 1062 patients with EA were divided at the end of the 2 years of follow-up into 49.9% with RA and 50.1% without RA. This latter group included patients with undifferentiated arthritis (20%) and ...

TORONTO — The lack of clinical trials testing the efficacy of treatments for axial disease in juvenile spondyloarthritis (axJSpA) remains a large unmet need, according to experts. Now, the first-ever, ...

TORONTO — After almost 10 years, the much-anticipated revision of the current classification criteria for axial spondyloarthritis (axSpA) is ready for prime time. An abstract of the modified criteria ...

The European Alliance of Associations for Rheumatology—has developed the first classification criteria for hemochromatosis arthropathy (HA) from a unique derivation cohort using rigorous methodology.

Diagnosing lupus can be challenging because the disease presents so differently from one person to the next. For that reason, multiple classification systems exist today to help researchers and ...

HA is distinctive arthropathy associated with genetic haemochromatosis – a condition where iron levels build up over time. This has many consequences, including liver cirrhosis, diabetes, and a ...

EULAR - The European Alliance of Associations for Rheumatology - has developed the first classification criteria for hemochromatosis arthropathy (HA) from a unique derivation cohort using rigorous ...

Antiphospholipid syndrome (APS) is a systemic autoimmune disease associated with persistent antiphospholipid antibodies (aPL). It can cause thrombosis and pregnancy complications as well as ...

Classification criteria developed using machine learning will allow doctors to conduct disease-specific research about this collection of inflammatory eye diseases. The Standardization of Uveitis ...

APS is a systemic autoimmune disease associated with persistent antiphospholipid antibodies (aPL). It can cause thrombosis and pregnancy complications as well as non-thrombotic manifestations such as ...